Member News, Funding news Steven Scott Member News, Funding news Steven Scott

Ingenza awarded government funding to develop novel carbon capture technology

Biotechnology company Ingenza is delighted to announce that its recent partnership with Johnson Matthey has been selected to receive vital funding of £441,632.88 from the Department of Business, Energy and Industrial Strategy as part of the £1 billion fund from the Net Zero Innovation Portfolio, which aims to slash emissions and energy costs.

Read More
Member News Steven Scott Member News Steven Scott

CuanTec welcomes Ivan McKee, MSP, and Directors from Scottish Government to Oban R&D Labs

CuanTec recently hosted a visit by Ivan McKee, MSP, and Directors from the Scottish Government and Highlands and Islands Enterprise (HIE), to learn about the company’s proprietary naturally derived biological, zero-carbon processes that eliminates existing shellfish waste and carbon emissions while replacing polluting or toxic products in the environment.

Read More
Member News Steven Scott Member News Steven Scott

OCEANIUM part of new SeaMark EU consortium for the seaweed industry

OCEANIUM is part of a new industry-wide consortium funded by the European Union which will propel the seaweed farming industry across Europe. SeaMark is a consortium comprising 25 international, cross-disciplinary partners which has been awarded a prestigious €9 million grant to upscale seaweed production and market applications across Europe, meet the growing demand for seaweed-based products and attract investment from multiple sectors.

Read More
Funding news, Industry News, Member News Steven Scott Funding news, Industry News, Member News Steven Scott

Biorenewables Development Centre is involved in two new projects aimed at decarbonising the UK transport sector.

The Biorenewables Development Centre (BDC) is part of two new Hydrogen BECCS (Bioenergy with Carbon Capture and Storage) Innovation Programme projects which has been funded by the Net Zero Innovation Portfolio (NZIP) that have been awarded by the Department for Business, Energy and Industrial Strategy (BEIS).

Read More
Member News, Stakeholder news, Industry News Steven Scott Member News, Stakeholder news, Industry News Steven Scott

Absolute Antibody Increases Automation Capabilities and Expands Production Facility to Support Continued Growth of its Recombinant Antibody Technology

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, has announced the near doubling of its manufacturing facility in northeast England. The increased laboratory space includes a major investment in new automation for Next Generation Sequencing (NGS), expression and purification (HPLC) to enhance recombinant antibody production workflows.

Read More
Member News, Funding news Steven Scott Member News, Funding news Steven Scott

Bio-Sep secures $1.7m from investors including London Business School’s Enterprise 100 investment club and ACF Investors for green-tech that turns sawdust into valuable biochemicals

Bio-Sep – a sustainable startup converting low-value sawdust into high-value biochemicals – has secured $1.7 million in an oversubscribed seed round led by London Business School’s Enterprise 100 Club (E100 Club) and ACF Investors, with additional participation from a hedge fund that specialises in climate and clean energy technology.

Read More
Steven Scott Steven Scott

Absolute Antibody Expands Prometheus™ Antibody Humanization Service to Include Non-Murine Origin Species

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the expansion of its Prometheus™ antibody humanization service to offer humanization from non-murine origin species, including rabbit antibodies and single-domain camelid nanobodies. The service can now deliver humanized antibodies from a wide range of species, while maintaining antibody expression levels and functionality.

Read More
IBioIC News, Industry News Steven Scott IBioIC News, Industry News Steven Scott

Scotland’s industrial biotechnology sector anticipated to surpass £1 billion turnover milestone by 2025

Scotland’s industrial biotechnology community is exceeding growth expectations and is on track to achieve annual turnover of £1.2bn by 2025, according to a refreshed strategy being launched at the Industrial Biotechnology Innovation Centre’s (IBioIC) annual conference today (June 6th).

Read More